Nutritional supplementation with HMB, arginine and glutamine in hospitalised older adults: the NOURISH trial secondary analysis of mortality
Deutz NE, Matheson EM, Matarese LE, Luo M, Baggs GE, Nelson JL, Hegazi RA, Tappenden KA, Ziegler TR
Published in Clinical Nutrition
Methodology
Randomised, double-blind, placebo-controlled trial of a high-protein oral nutritional supplement containing HMB in 652 malnourished hospitalised older adults
Key Findings
Ninety-day mortality was significantly lower with the HMB-containing supplement (4.8% vs 9.7%), although the primary composite of readmission or death was unchanged.
Conclusions
HMB-containing nutritional support reduced mortality in malnourished hospitalised older adults.
Limitations
Multi-nutrient supplement; HMB effect cannot be isolated; industry sponsored.
Supplements Studied
Ninety-day mortality was significantly lower with the HMB-containing supplement (4.8% vs 9.7%).
Outcomes Measured
Ninety-day mortality was significantly lower with the HMB-containing supplement (4.8% vs 9.7%).
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.